Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06143397
Status:
RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-11-16
Brief Title:
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis
Sponsor:
Prof Dr Cemil Tascıoglu Education and Research Hospital Organization
Organization:
Prof Dr Cemil Tascıoglu Education and Research Hospital Organization
Study Overview
Official Title:
Effect of Transcutaneous Posterior Tibial Nerve Stimulation and Parasacral Transcutaneous Electrical Stimulation on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the use of transcutaneous tibial nerve stimulation TTNS and parasacral nerve stimulation PSS methods in the treatment of overactive bladder OAB symptoms in patients with Multiple Sclerosis MS including urination frequency urgency urinary incontinence post-void residue maximum micturition rate To investigate the effect on parameters such as voiding volume and quality of life and to compare the final results between groups
Detailed Description:
Participants will be divided into 3 groups TTNS PNS and placebo groups and all participants will be given behavioral treatment Tibial nerve stimulation will be given to the TTNS group sacral nerve stimulation will be given to the PNS group and sham current will be given to the placebo group Stimulation treatments will be applied 2 days a week for 30 minutes each for 6 weeks Participants will be evaluated before and after treatment The parameters of urination frequency urgency and urinary incontinence will be evaluated with a 3-day voiding diary BD maximum flow rate Qmax time to reach maximum flow TQmax average flow rate flow time Tw voiding time and voiding volume VV values will be evaluated by uroflowmetry post-voiding residual PVR volume will be evaluated by ultrasound and quality of life will be evaluated by Kings Quality of Life Questionnaire KHQ Expanded Disability Status Scale EDSS Overactive bladder form OAB-v8 Incontinence Severity Index ISI Neurogenic Bladder Symptom Score NBSS will be recorded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None